UPDATE : Monday, September 7, 2020
상단여백
Sillajen to expand clinical design for Pexa-Vec in US by Lee Han-soo 2020-03-05 15:57
Hanmi’s NASH treatment wins orphan drug status by Lee Han-soo 2020-03-05 14:45
GC gets item license from regulator by Shim Hyun-tai 2020-03-04 17:21
JW Creagene wins patent to make dendritic cell treatment by Lee Han-soo 2020-03-04 17:20
US attorney says Daewoong used Medytox's BTX strain by Lee Han-soo 2020-03-04 15:55
라인
Korea nods testing remdesivir in COVID-19 patients by Kim Yun-mi 2020-03-04 13:46
GSK loses out to local drugmakers in quadrivalent flu vaccine sales by Jeong Sae-im 2020-03-04 12:05
ImmuneMed tests new drug candidate VSF on COVID-19 patients by Shim Hyun-tai 2020-03-03 16:59
US firm to test potential coronavirus vaccine mRNA-1273 by Kim Yun-mi 2020-03-03 15:29
Whanin to sell Gedeon Richter’s schizophrenia treatment by Lee Han-soo 2020-03-02 16:55
라인
[Special] Allergan’s dominance at stake in Daewoong-Medytox BTX battle by Park Gi-taek 2020-03-02 14:43
Kainos Med’s HIV drug enters final stage of phase-3 trial by Shim Hyun-tai 2020-02-28 17:07
GSK, Clover collaborate on research for COVID-19 vaccine candidate by Shim Hyun-tai 2020-02-28 12:25
Hanmi, GC to co-develop rare diseases treatments by Lee Han-soo 2020-02-27 16:50
JW Shinyak launches new hand eczema treatment by Lee Han-soo 2020-02-27 16:50
라인
FDA OKs 2 phase-3 clinical trials for Gilead's Remdesivir by Shim Hyun-tai 2020-02-27 16:08
Alvogen Korea wins anti-bribery system certification by Lee Han-soo 2020-02-27 12:10
Huons Global posts ₩449.4 billion in 2019 sales by Lee Han-soo 2020-02-26 16:15
US begins to test remdesivir for COVID-19 treatment by Kim Yun-mi 2020-02-26 15:21
Novo Nordisk’s Saxenda remains at top in obesity treatment sales by Shim Hyun-tai 2020-02-25 18:12
여백
여백
여백
Back to Top